Literature DB >> 24121811

Overdrive pacing in a patient with incessant torsades de pointes.

Adam N Overbey1, Andrea Austin, Daniel F Seidensticker, Andrew H Lin.   

Abstract

A 75-year-old man presented to the emergency department (ED) for syncope and was found to have intermittent runs of torsades de pointes (TdP). The patient had a medical history significant for disseminated coccidiomycosis and was on prophylactic fluconazole. Forty-eight hours prior to presentation, the patient had intractable nausea and vomiting and was unable to take anything orally. He eventually presented to the ED with severe hypokalaemia and hypomagnesaemia with repeat symptomatic runs of TdP, which required overdrive transvenous pacing. During the patient''s admission, his electrolytes were aggressively replete. Fluconazole was discontinued, and prior to discharge, the patient recovered fully with ECGs showing a normalisation of the QT interval.

Entities:  

Mesh:

Year:  2013        PMID: 24121811      PMCID: PMC3822076          DOI: 10.1136/bcr-2013-200146

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Long QT syndrome: diagnosis and management.

Authors:  Ijaz A Khan
Journal:  Am Heart J       Date:  2002-01       Impact factor: 4.749

Review 2.  Drug induced QT prolongation and torsades de pointes.

Authors:  Yee Guan Yap; A John Camm
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

Review 3.  Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Robert W Neumar; Charles W Otto; Mark S Link; Steven L Kronick; Michael Shuster; Clifton W Callaway; Peter J Kudenchuk; Joseph P Ornato; Bryan McNally; Scott M Silvers; Rod S Passman; Roger D White; Erik P Hess; Wanchun Tang; Daniel Davis; Elizabeth Sinz; Laurie J Morrison
Journal:  Circulation       Date:  2010-11-02       Impact factor: 29.690

4.  Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System.

Authors:  Elisabetta Poluzzi; Emanuel Raschi; Domenico Motola; Ugo Moretti; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

5.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-09-05       Impact factor: 24.094

6.  Treatment of torsade de pointes with magnesium sulfate.

Authors:  D Tzivoni; S Banai; C Schuger; J Benhorin; A Keren; S Gottlieb; S Stern
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

7.  Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Authors:  Barbara J Drew; Michael J Ackerman; Marjorie Funk; W Brian Gibler; Paul Kligfield; Venu Menon; George J Philippides; Dan M Roden; Wojciech Zareba
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

8.  Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death.

Authors:  Sabine M J M Straus; Miriam C J M Sturkenboom; Gysèle S Bleumink; Jeanne P Dieleman; Johan van der Lei; Pieter A de Graeff; Jan Herre Kingma; Bruno H Ch Stricker
Journal:  Eur Heart J       Date:  2005-05-11       Impact factor: 29.983

Review 9.  Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.

Authors:  David Zeltser; Dan Justo; Amir Halkin; Vitaly Prokhorov; Karin Heller; Sami Viskin
Journal:  Medicine (Baltimore)       Date:  2003-07       Impact factor: 1.889

10.  The "R-on-T" phenomenon: an update and critical review.

Authors:  T R Engel; S G Meister; W S Frankl
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

View more
  3 in total

Review 1.  Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.

Authors:  Gerrit Frommeyer; Lars Eckardt
Journal:  Nat Rev Cardiol       Date:  2015-07-21       Impact factor: 32.419

2.  Autonomic conflict exacerbates long QT associated ventricular arrhythmias.

Authors:  James Winter; Michael J Tipton; Michael J Shattock
Journal:  J Mol Cell Cardiol       Date:  2018-02-02       Impact factor: 5.000

3.  Loperamide overdose causing torsades de pointes and requiring Impella temporary mechanical support: a case report.

Authors:  Jonathan D Cicci; Sarah M Jagielski; Megan M Clarke; Robert A Rayson; Matthew A Cavender
Journal:  Eur Heart J Case Rep       Date:  2019-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.